These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 29866817)

  • 1. von Willebrand factor regulation of blood vessel formation.
    Randi AM; Smith KE; Castaman G
    Blood; 2018 Jul; 132(2):132-140. PubMed ID: 29866817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial von Willebrand factor regulates angiogenesis.
    Starke RD; Ferraro F; Paschalaki KE; Dryden NH; McKinnon TA; Sutton RE; Payne EM; Haskard DO; Hughes AD; Cutler DF; Laffan MA; Randi AM
    Blood; 2011 Jan; 117(3):1071-80. PubMed ID: 21048155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor and angiogenesis: basic and applied issues.
    Randi AM; Laffan MA
    J Thromb Haemost; 2017 Jan; 15(1):13-20. PubMed ID: 27778439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in von Willebrand disease: angiogenesis and angiodysplasia.
    Randi AM
    Thromb Res; 2016 May; 141 Suppl 2():S55-8. PubMed ID: 27207426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study.
    Groeneveld DJ; Sanders YV; Adelmeijer J; Mauser-Bunschoten EP; van der Bom JG; Cnossen MH; Fijnvandraat K; Laros-van Gorkom BAP; Meijer K; Lisman T; Eikenboom J; Leebeek FWG
    Thromb Haemost; 2018 Jan; 118(1):152-160. PubMed ID: 29304535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.
    Haberichter SL; Merricks EP; Fahs SA; Christopherson PA; Nichols TC; Montgomery RR
    Blood; 2005 Jan; 105(1):145-52. PubMed ID: 15331450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic characteristics of blood outgrowth endothelial cells from patients with von Willebrand disease.
    Groeneveld DJ; van Bekkum T; Dirven RJ; Wang JW; Voorberg J; Reitsma PH; Eikenboom J
    J Thromb Haemost; 2015 Oct; 13(10):1854-66. PubMed ID: 26270243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular studies of von Willebrand disease: reduced von Willebrand factor biosynthesis, storage, and release in endothelial cells derived from patients with type I von Willebrand disease.
    Ewenstein BM; Inbal A; Pober JS; Handin RI
    Blood; 1990 Apr; 75(7):1466-72. PubMed ID: 2317558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Willebrand factor, angiodysplasia and angiogenesis.
    Randi AM; Laffan MA; Starke RD
    Mediterr J Hematol Infect Dis; 2013 Sep; 5(1):e2013060. PubMed ID: 24106610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations.
    Ocran E; Chornenki NLJ; Bowman M; Sholzberg M; James P
    Expert Rev Hematol; 2023; 16(8):575-584. PubMed ID: 37278227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.
    Selvam S; James P
    Semin Thromb Hemost; 2017 Sep; 43(6):572-580. PubMed ID: 28476066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Manifold Cellular Functions of von Willebrand Factor.
    Mojzisch A; Brehm MA
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand disease and Weibel-Palade bodies.
    Wang JW; Eikenboom J
    Hamostaseologie; 2010 Aug; 30(3):150-5. PubMed ID: 20680229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [von Willebrand factor and von Willebrand disease].
    Matsui T; Hamako J
    Rinsho Ketsueki; 2016; 57(10):2113-2123. PubMed ID: 27795521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients.
    Selvam SN; Casey LJ; Bowman ML; Hawke LG; Longmore AJ; Mewburn J; Ormiston ML; Archer SL; Maurice DH; James P
    Blood Coagul Fibrinolysis; 2017 Oct; 28(7):521-533. PubMed ID: 28362648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor propeptide missense variants affect anterograde transport to Golgi resulting in ER retention.
    Yadegari H; Biswas A; Ahmed S; Naz A; Oldenburg J
    Hum Mutat; 2021 Jun; 42(6):731-744. PubMed ID: 33942438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells.
    Bowman M; Casey L; Selvam SN; Lima PDA; Rawley O; Hinds M; Tuttle A; Grabell J; Iorio A; Walker I; Lillicrap D; James P
    J Thromb Haemost; 2022 Jul; 20(7):1599-1609. PubMed ID: 35466528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease.
    Wang JW; Valentijn KM; de Boer HC; Dirven RJ; van Zonneveld AJ; Koster AJ; Voorberg J; Reitsma PH; Eikenboom J
    J Biol Chem; 2011 Jul; 286(27):24180-8. PubMed ID: 21596755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
    Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
    Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dispatch and delivery at the ER-Golgi interface: how endothelial cells tune their hemostatic response.
    Kat M; Margadant C; Voorberg J; Bierings R
    FEBS J; 2022 Nov; 289(22):6863-6870. PubMed ID: 35246944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.